Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonidas Mavroeidis

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Letters|December 27, 2016
Metronomic chemotherapy: A potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activationEirini Biziota, Leonidas Mavroeidis, Eleftheria Hatzimichael, et al.
Rare Tumors|February 19, 2024
Real-world evidence for ultra rare cancersLeonidas Mavroeidis, Andrea Napolitano, Paul Huang, et al.
Cancers|January 11, 2025
Novel Therapeutics in Soft Tissue SarcomaLeonidas Mavroeidis, Andrea Napolitano, Paul Huang, et al.
Anti-Cancer Drugs|December 3, 2015
Cellular and molecular effects of metronomic vinorelbine and 4-O-deacetylvinorelbine on human umbilical vein endothelial cellsEirini Biziota, Evangelos Briasoulis, Leonidas Mavroeidis, et al.
Expert Review of Gastroenterology & Hepatology|March 29, 2025
Identifying and managing rare subtypes of gastrointestinal stromal tumorsLeonidas Mavroeidis, Foteini Kalofonou, Ruth Casey, et al.
Case Reports in Oncology|February 29, 2020
Acquired Hemophilia in an Elderly Patient with Carcinoma of the Ampulla of VaterLeonidas Mavroeidis, Amalia Vassou, George Zarkavelis, et al.
Contemporary Oncology (Poznan, Poland)|June 10, 2020
The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literatureGeorge Zarkavelis, Davide Mauri, Fotini Karassa, et al.
Frontiers in Endocrinology|December 28, 2020
Chemotherapy Associated Ovarian FailureDavide Mauri, Ioanna Gazouli, Georgios Zarkavelis, et al.
ESMO Open|February 8, 2021
Old drug, new clinical use, no man's land for the indication: an awareness call from European expertsStefan Rauh, Leonidas Mavroeidis, Panagiotis Ntellas, et al.
Cancers|October 30, 2020
Old Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in CancerPanagiotis Ntellas, Leonidas Mavroeidis, Stefania Gkoura, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Letters|December 27, 2016
Metronomic chemotherapy: A potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activationEirini Biziota, Leonidas Mavroeidis, Eleftheria Hatzimichael, et al.
Rare Tumors|February 19, 2024
Real-world evidence for ultra rare cancersLeonidas Mavroeidis, Andrea Napolitano, Paul Huang, et al.
Cancers|January 11, 2025
Novel Therapeutics in Soft Tissue SarcomaLeonidas Mavroeidis, Andrea Napolitano, Paul Huang, et al.
Anti-Cancer Drugs|December 3, 2015
Cellular and molecular effects of metronomic vinorelbine and 4-O-deacetylvinorelbine on human umbilical vein endothelial cellsEirini Biziota, Evangelos Briasoulis, Leonidas Mavroeidis, et al.
Expert Review of Gastroenterology & Hepatology|March 29, 2025
Identifying and managing rare subtypes of gastrointestinal stromal tumorsLeonidas Mavroeidis, Foteini Kalofonou, Ruth Casey, et al.
Case Reports in Oncology|February 29, 2020
Acquired Hemophilia in an Elderly Patient with Carcinoma of the Ampulla of VaterLeonidas Mavroeidis, Amalia Vassou, George Zarkavelis, et al.
Contemporary Oncology (Poznan, Poland)|June 10, 2020
The cancer immunotherapy environment may confound the utility of anti-TIF-1γ in differentiating between paraneoplastic and treatment-related dermatomyositis. Report of a case and review of the literatureGeorge Zarkavelis, Davide Mauri, Fotini Karassa, et al.
Frontiers in Endocrinology|December 28, 2020
Chemotherapy Associated Ovarian FailureDavide Mauri, Ioanna Gazouli, Georgios Zarkavelis, et al.
ESMO Open|February 8, 2021
Old drug, new clinical use, no man's land for the indication: an awareness call from European expertsStefan Rauh, Leonidas Mavroeidis, Panagiotis Ntellas, et al.
Cancers|October 30, 2020
Old Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in CancerPanagiotis Ntellas, Leonidas Mavroeidis, Stefania Gkoura, et al.
Pageof 2